243 related articles for article (PubMed ID: 17120594)
1. Headache, Raynaud's syndrome and serotonin receptor agonists in systemic lupus erythematosus.
Bernatsky S; Pineau CA; Lee JL; Clarke AE
Lupus; 2006; 15(10):671-4. PubMed ID: 17120594
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and factors associated with headache in patients with systemic lupus erythematosus.
Weder-Cisneros ND; Téllez-Zenteno JF; Cardiel MH; Guibert-Toledano M; Cabiedes J; Velásquez-Paz AL; García-Ramos G; Cantú C
Cephalalgia; 2004 Dec; 24(12):1031-44. PubMed ID: 15566417
[TBL] [Abstract][Full Text] [Related]
3. Raynaud's phenomenon in systemic lupus erythematosus.
Lavras Costallat LT; Valente Coimbra AM
Rev Rhum Engl Ed; 1995 May; 62(5):349-53. PubMed ID: 7655867
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications of migraine in systemic lupus erythematosus: relation to cumulative organ damage.
Appenzeller S; Costallat LT
Cephalalgia; 2004 Dec; 24(12):1024-30. PubMed ID: 15566416
[TBL] [Abstract][Full Text] [Related]
5. Increased urotensin-II activity in patients with Raynaud's phenomenon and systemic lupus erythematosus.
Buyukhatipoglu H; Buyukaslan H; Pehlivan Y; Ceylan N; Ulas T; Tarakcioglu M; Onat AM
Int J Rheum Dis; 2011 Aug; 14(3):276-81. PubMed ID: 21816024
[TBL] [Abstract][Full Text] [Related]
6. Headaches in patients with systemic lupus erythematosus: a comparative study.
Whitelaw DA; Hugo F; Spangenberg JJ; Rickman R
Lupus; 2004; 13(7):501-5. PubMed ID: 15352420
[TBL] [Abstract][Full Text] [Related]
7. Headache in systemic lupus erythematosus: a controlled study.
Sfikakis PP; Mitsikostas DD; Manoussakis MN; Foukaneli D; Moutsopoulos HM
Br J Rheumatol; 1998 Mar; 37(3):300-3. PubMed ID: 9566671
[TBL] [Abstract][Full Text] [Related]
8. Association between Raynaud's phenomenon and migraine in a random population of hospital employees.
O'Keeffe ST; Tsapatsaris NP; Beetham WP
J Rheumatol; 1993 Jul; 20(7):1187-8. PubMed ID: 8371215
[TBL] [Abstract][Full Text] [Related]
9. The clinical significance of Raynaud's syndrome.
Porter JM; Bardana EJ; Baur GM; Wesche DH; Andrasch RH; Rösch J
Surgery; 1976 Dec; 80(6):756-64. PubMed ID: 1006524
[TBL] [Abstract][Full Text] [Related]
10. The clinical significance of Raynaud's phenomenon in systemic lupus erythematosus.
Dimant J; Ginzler E; Schlesinger M; Sterba G; Diamond H; Kaplan D; Weiner M
Arthritis Rheum; 1979 Aug; 22(8):815-9. PubMed ID: 465096
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and classification of headache in patients with systemic lupus erythematosus.
Lessa B; Santana A; Lima I; Almeida JM; Santiago M
Clin Rheumatol; 2006 Nov; 25(6):850-3. PubMed ID: 16437362
[TBL] [Abstract][Full Text] [Related]
12. Smoking, alcohol consumption, and Raynaud's phenomenon in middle age.
Suter LG; Murabito JM; Felson DT; Fraenkel L
Am J Med; 2007 Mar; 120(3):264-71. PubMed ID: 17349450
[TBL] [Abstract][Full Text] [Related]
13. Clinical Study on Systemic Lupus Erythematosus Complicated with Knee Bone Infarction.
Zhu GQ; Qiu HX; Ma XM; Liu MX
Int J Clin Pract; 2022; 2022():7025811. PubMed ID: 35936062
[TBL] [Abstract][Full Text] [Related]
14. Systemic lupus erythematosus and Raynaud's phenomenon.
Heimovski FE; Simioni JA; Skare TL
An Bras Dermatol; 2015; 90(6):837-40. PubMed ID: 26734864
[TBL] [Abstract][Full Text] [Related]
15. Myositis in systemic lupus erythematosus.
Cotton T; Niaki OZ; Zheng B; Pineau CA; Fritzler M; Vinet E; Clarke AE; Bernatsky S
Lupus; 2021 Apr; 30(4):615-619. PubMed ID: 33461416
[TBL] [Abstract][Full Text] [Related]
16. The diagnosis and treatment of Raynaud's phenomenon: a practical approach.
Pope JE
Drugs; 2007; 67(4):517-25. PubMed ID: 17352512
[TBL] [Abstract][Full Text] [Related]
17. [Migraine in SLE: role of antiphospholipid antibodies and Raynaud's phenomenon].
Annese V; Tomietto P; Venturini P; D'Agostini S; Ferraccioli G
Reumatismo; 2006; 58(1):50-8. PubMed ID: 16639488
[TBL] [Abstract][Full Text] [Related]
18. A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies.
Cavazzana I; Fredi M; Taraborelli M; Quinzanini M; Tincani A; Franceschini F
Clin Exp Rheumatol; 2013; 31(2 Suppl 76):118-21. PubMed ID: 23910615
[TBL] [Abstract][Full Text] [Related]
19. [Calcium antagonists and Raynaud's phenomenon].
Hachulla E; Devulder B
Therapie; 1993; 48 Spec No():707-11. PubMed ID: 8091357
[TBL] [Abstract][Full Text] [Related]
20. Reproducibility of cold provocation in patients with Raynaud's phenomenon.
Wigley FM; Malamet R; Wise RA
J Rheumatol; 1987 Aug; 14(4):751-5. PubMed ID: 3668980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
